April 3, 2017 / 5:05 AM / 4 months ago

BRIEF-Kiadis Pharma receives regulatory approval for next trials for ATIR101 and ATIR201

1 Min Read

April 3 (Reuters) - Kiadis Pharma NV:

* Kiadis Pharma announces positive regulatory update on ATIR101 and ATIR201

* Regulatory approval received from national authority in Belgium to start pivotal phase III trial with ATIR101

* Regulatory approval received from national authority in Germany to start phase I/II trial with ATIR201 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below